BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

530 related articles for article (PubMed ID: 23913633)

  • 21. Influence of vascular endothelial growth factor single nucleotide polymorphisms on non-small cell lung cancer tumor angiogenesis.
    Maeda A; Nakata M; Yasuda K; Yukawa T; Saisho S; Okita R; Hirami Y; Shimizu K
    Oncol Rep; 2013 Jan; 29(1):39-44. PubMed ID: 23064377
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Elevated expression of BIRC6 protein in non-small-cell lung cancers is associated with cancer recurrence and chemoresistance.
    Dong X; Lin D; Low C; Vucic EA; English JC; Yee J; Murray N; Lam WL; Ling V; Lam S; Gout PW; Wang Y
    J Thorac Oncol; 2013 Feb; 8(2):161-70. PubMed ID: 23287853
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The role of CD133 expression in the carcinogenesis and prognosis of patients with lung cancer.
    Le H; Zeng F; Xu L; Liu X; Huang Y
    Mol Med Rep; 2013 Nov; 8(5):1511-8. PubMed ID: 24008862
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Relation of hypoxia inducible factor 1 alpha and 2 alpha in operable non-small cell lung cancer to angiogenic/molecular profile of tumours and survival.
    Giatromanolaki A; Koukourakis MI; Sivridis E; Turley H; Talks K; Pezzella F; Gatter KC; Harris AL
    Br J Cancer; 2001 Sep; 85(6):881-90. PubMed ID: 11556841
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Vascular endothelial growth factor and osteopontin in stage I lung adenocarcinoma.
    Shijubo N; Uede T; Kon S; Maeda M; Segawa T; Imada A; Hirasawa M; Abe S
    Am J Respir Crit Care Med; 1999 Oct; 160(4):1269-73. PubMed ID: 10508818
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Interleukin-8 in non-small cell lung carcinoma: relation with angiogenic pattern and p53 alterations.
    Boldrini L; Gisfredi S; Ursino S; Lucchi M; Mussi A; Basolo F; Pingitore R; Fontanini G
    Lung Cancer; 2005 Dec; 50(3):309-17. PubMed ID: 16125276
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Vascular endothelial growth factor is associated with neovascularization and influences progression of non-small cell lung carcinoma.
    Fontanini G; Vignati S; Boldrini L; Chinè S; Silvestri V; Lucchi M; Mussi A; Angeletti CA; Bevilacqua G
    Clin Cancer Res; 1997 Jun; 3(6):861-5. PubMed ID: 9815760
    [TBL] [Abstract][Full Text] [Related]  

  • 28. WT1 promotes invasion of NSCLC via suppression of CDH1.
    Wu C; Zhu W; Qian J; He S; Wu C; Chen Y; Shu Y
    J Thorac Oncol; 2013 Sep; 8(9):1163-9. PubMed ID: 23945386
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Insulin-like growth factor receptor 1 mRNA expression as a prognostic marker in advanced non-small cell lung cancer.
    Vilmar A; Santoni-Rugiu E; Cillas JG; Huarriz M; Sørensen JB
    Anticancer Res; 2014 Jun; 34(6):2991-6. PubMed ID: 24922664
    [TBL] [Abstract][Full Text] [Related]  

  • 30. VEGF neutralizing aerosol therapy in primary pulmonary adenocarcinoma with K-ras activating-mutations.
    Hervé V; Rabbe N; Guilleminault L; Paul F; Schlick L; Azzopardi N; Duruisseaux M; Fouquenet D; Montharu J; Redini F; Paintaud G; Lemarié E; Cadranel J; Wislez M; Heuzé-Vourc'h N
    MAbs; 2014; 6(6):1638-48. PubMed ID: 25484066
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Comparative evaluation of angiogenesis assessment with anti-factor-VIII and anti-CD31 immunostaining in non-small cell lung cancer.
    Giatromanolaki A; Koukourakis MI; Theodossiou D; Barbatis K; O'Byrne K; Harris AL; Gatter KC
    Clin Cancer Res; 1997 Dec; 3(12 Pt 1):2485-92. PubMed ID: 9815651
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Downregulation of the TGFβ Pseudoreceptor BAMBI in Non-Small Cell Lung Cancer Enhances TGFβ Signaling and Invasion.
    Marwitz S; Depner S; Dvornikov D; Merkle R; Szczygieł M; Müller-Decker K; Lucarelli P; Wäsch M; Mairbäurl H; Rabe KF; Kugler C; Vollmer E; Reck M; Scheufele S; Kröger M; Ammerpohl O; Siebert R; Goldmann T; Klingmüller U
    Cancer Res; 2016 Jul; 76(13):3785-801. PubMed ID: 27197161
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Modulation of TLR9 on anti-tumor immune responses of peripheral blood mononuclear cells from patients with non-small-cell lung cancer].
    Ren T; Cai YY; Liang YJ; Jin ML; Guo ZL; Tao MF; He X
    Zhonghua Yi Xue Za Zhi; 2008 Apr; 88(17):1168-72. PubMed ID: 18844109
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Diversity of the angiogenic phenotype in non-small cell lung cancer.
    McClelland MR; Carskadon SL; Zhao L; White ES; Beer DG; Orringer MB; Pickens A; Chang AC; Arenberg DA
    Am J Respir Cell Mol Biol; 2007 Mar; 36(3):343-50. PubMed ID: 17079777
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Clinical significance of expression of cancer/testis antigen and down-regulation of HLA class-I in patients with stage I non-small cell lung cancer.
    Hanagiri T; Shigematsu Y; Shinohara S; Takenaka M; Oka S; Chikaishi Y; Nagata Y; Baba T; Uramoto H; So T; Yamada S
    Anticancer Res; 2013 May; 33(5):2123-8. PubMed ID: 23645764
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Up-regulation of vascular endothelial growth factor/vascular permeability factor in mouse skin carcinogenesis correlates with malignant progression state and activated H-ras expression levels.
    Larcher F; Robles AI; Duran H; Murillas R; Quintanilla M; Cano A; Conti CJ; Jorcano JL
    Cancer Res; 1996 Dec; 56(23):5391-6. PubMed ID: 8968091
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Vascular endothelial growth factor expression in non-small-cell lung cancer: prognostic significance in squamous cell carcinoma.
    Imoto H; Osaki T; Taga S; Ohgami A; Ichiyoshi Y; Yasumoto K
    J Thorac Cardiovasc Surg; 1998 May; 115(5):1007-14. PubMed ID: 9605068
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Antiapoptotic activity of autocrine interleukin-22 and therapeutic effects of interleukin-22-small interfering RNA on human lung cancer xenografts.
    Zhang W; Chen Y; Wei H; Zheng C; Sun R; Zhang J; Tian Z
    Clin Cancer Res; 2008 Oct; 14(20):6432-9. PubMed ID: 18927282
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Endobronchial ultrasound doppler image features correlate with mRNA expression of HIF1-α and VEGF-C in patients with non-small-cell lung cancer.
    Nakajima T; Anayama T; Koike T; Shingyoji M; Castle L; Kimura H; Yoshino I; Yasufuku K
    J Thorac Oncol; 2012 Nov; 7(11):1661-7. PubMed ID: 23059773
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Vascular endothelial growth factor, wild-type p53, and angiogenesis in early operable non-small cell lung cancer.
    Giatromanolaki A; Koukourakis MI; Kakolyris S; Turley H; O'Byrne K; Scott PA; Pezzella F; Georgoulias V; Harris AL; Gatter KC
    Clin Cancer Res; 1998 Dec; 4(12):3017-24. PubMed ID: 9865915
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 27.